How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 1
In Part 1 of a 3 part blog series, we will explore how the heritability of neurological diseases and psychiatric diseases is changing the clinical…
New Whitepaper: The Microbiome in Clinical Trials – Opportunities and Challenges
Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in…
How to Avoid the Hidden Costs of Clinical Trials
The cost of conducting a clinical trial is indisputably expensive and time consuming. In this post, we present some practices that could help you execute…
Duchenne Muscular Dystrophy: Challenges in Clinical Research
Duchenne Muscular Dystrophy (DMD) is a specific type of muscular dystrophy characterized by muscle weakness and deterioration. DMD research comes with its fair share of…
Spotlight on Mexico – Rich in clinical research capabilities and benefits
Mexico is quickly becoming a major player in the pharmaceutical and medical device industries. It’s the number one exporter of medical devices in Latin America…
How important is patient-centricity in rare disease studies?
Patient-centricity is becoming increasingly important in all areas, but particularly in rare diseases. In this post, Dr. Richard Scheyer discusses the importance of patient-centricity in…
How to Leverage Research Networks to Accelerate Orphan Drug Development
In this post, Dr. Terence Eagleton highlights the growing interest in the development of products in the rare disease space, the unique challenges involved, and…
Shortened Timelines for Regulatory Review by ANMAT Make Argentina an Excellent Choice for Clinical Research
Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace
On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation…
Q&A with Dr. Brian Murphy, VP of Medical Affairs for Infectious Diseases
In this post, Dr. Brian Murphy, Vice President of Medical Affairs for Infectious Diseases, discusses the following topic: “Source Control Review in Clinical Trials of…
The Promising Landscape of Microbiome-based Clinical Research
Recent discoveries have been made that have revealed the power of microbes to prevent, diagnose, and treat disease. As a result of these discoveries, clinical…